(PharmaNewsWire.Com, May 03, 2017 ) According to Publisher, the Global Multiplex Assays market is accounted for $2.68 billion in 2015 and is expected to reach $4.7 billion by 2022 growing at a CAGR of 8.1% from 2015 to 2022. Growing demand for high throughput and automated systems will offer a significant growth opportunity over the forecast period. Some factors such as rising safety & efficacy of therapies, growing advantages of multiplexing over conventional assays and improving validation for biomarkers are contributing the market growth. However, huge capital investments and shortage of skilled labour are negatively affecting the market.
R&D segment registered a largest market share during the forecast period attributed to easy and closer grades offered by multiple assays. North America commanded the largest market share followed by Europe. Furthermore, Asia Pacific is expected to grow at a fastest rate during the forecast period.
Some of the key vendors participated in this market include Randox Laboratories Ltd., Seegene Inc., Becton, Dickinson and Company, Qiagen N.V., Illumina, Inc., Luminex Corporation, Meso Scale Diagnostics, LLC, Merck KGAA, Abcam PLC, Bio-Rad Laboratories Inc. and Thermo Fisher Scientific Inc.
Technologies Covered: - Multiplex Arrays o Multiplex Bead-Based Array o Multiplex Planar Arrays - Multiplex Pcr - Other Technologies
Product and Services Covered: - Multiplex Assay Accessories - Multiplex Assay Consumables - Multiplex Assay Instruments - Software and Services
End User Covered: - Hospitals - Academic & Research Institutes - Clinical Laboratories - Pharmaceutical & Biotechnology Companies - Other End Users
Assays Types Covered: - Protein-Based Multiplex Assays o Bead-Based Protein Assays o Planar Protein Assays - Nucleic Acid-Based Multiplex Assays o Bead-Based Nucleic Acid Assays o Planar Nucleic Acid Assays
Application Covered: - Companion Diagnostics - Research & Development o Biomarker Discovery and Validation o Drug Development - Diseases & Disorders o Allergies o Autoimmune Diseases o Cancer o Alzheimer’s Disease o Infectious Diseases o Cardiac Diseases
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
12 Company Profiling 12.1 Randox Laboratories Ltd. 12.2 Seegene Inc. 12.3 Becton, Dickinson and Company 12.4 Qiagen N.V. 12.5 Illumina, Inc. 12.6 Luminex Corporation 12.7 Meso Scale Diagnostics, LLC 12.8 Merck KGAA 12.12 Abcam PLC 12.10 Bio-Rad Laboratories Inc. 12.11 Thermo Fisher Scientific Inc.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
